Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R35CA232113-04
Targeting undruggable RAS for cancer treatment
National Institutes of Health
Grant: 5R01CA042978-26
Biological Activity of Ras Oncogenes
National Institutes of Health
Grant: 5P30CA036727-23
CORE--Confocal Microscopy
National Institutes of Health
Grant: 7R01CA157490-06
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
National Institutes of Health
Grant: 5P50CA196510-04
Washington University SPORE in Pancreatic Cancer
National Institutes of Health
Grant: 5P01CA203657-02
Defining RAS isoform- and mutation-specific roles in oncogenesis
National Institutes of Health
Grant: 1F32CA239328-01
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.
National Institutes of Health
Grant: 5T32CA009156-20
BASIC MECHANISMS OF VIRAL AND CHEMICAL CARCINOGENESIS
National Institutes of Health
Grant: 3U01CA199235-04S1
Identification of synthetic lethal interactors in pancreatic cancer
National Institutes of Health
Grant: 5R01GM095567-06
Mechanisms of Selective Autophagy
National Institutes of Health
Grant: 5T32CA071341-05
CANCER CELL BIOLOGY TRAINING PROGRAM
National Institutes of Health
Grant: 5R01CA175747-05
Mechanisms of PAK1 activation, signaling and tumor resistance
National Institutes of Health
Grant: 2R01CA163649-06A1
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
National Institutes of Health
Grant: 5F32CA232529-03
Defining the contributions of WT RAS in RAS-mutant lung cancer
National Institutes of Health
Grant: 5P01CA117969-03
Core A: Molecular Imaging Core
National Institutes of Health
Grant: 3F32CA200313-02S1
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5R01CA210439-05
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3R01CA216853-03S1
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
National Institutes of Health
Grant: 7R01CA188048-03
Investigating a novel glutamine metabolism pathway in pancreatic cancer
FWCI
0.95
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals